Report LibraryAll Reports
Datamonitor Healthcare Oncology: Breast Cancer: Triple-Negative Disease Coverage
Retail Price: $22,000.00*BioMedTracker Subscriber Price: $15,000.00 - click here to log in
May 09, 2018Triple-negative breast cancer is characterized by the absence of estrogen and progesterone receptors, and does not involve overexpression of human epidermal growth factor 2 (HER2). It is associated with poor prognosis, a high risk of local recurrence, and poor disease-free and cancer-specific survival. Overall, breast cancer is the second most common cancer and the second leading cause of cancer-related deaths in women worldwide. In the US, breast cancer is the third leading cause of cancer-related deaths, regardless of gender, behind lung cancer and colorectal cancer.
This Datamonitor Healthcare Disease report contains Forecast, Treatment, Epidemiology, Marketed Drugs, and Pipeline modules.
|Disease Group Covered:||Oncology|